A German drug maker is pledging millions of dollars for multiple sclerosis research, the company's U.S. subsidiary said Thursday.
A generic drug maker in India and a German pharmaceutical company will collaborate to develop biosimilars.
German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.
Merck KGaA announced that Robert Yates was named president of Merck Millipore, the drug maker's life science division.
German drug maker Merck KGaA said it finished enrolling patients in a late-stage clinical study of a drug for Parkinson's disease.
Merck KGaA division Merck Serono has appointed Belen Garijo as COO and Annalisa Jenkins as global head of drug development and medical, effective Sept. 5.
The Food and Drug Administration declined to approve a Merck KGaA drug designed to treat relapsing-remitting multiple sclerosis.
German drug maker Merck KGaA has finished acquiring U.S. life-sciences company Millipore, Merck KGaA said...
Merck KGaA plans to buy a Massachusetts life sciences company for $7.2 billion, the German...